Targeted and Checkpoint Inhibitor Therapy of Metastatic Malignant Melanoma in Germany, 2000–2016
- Supplementary File 1:
PDF-Document (PDF, 397 KiB)
Hellmund, P.; Schmitt, J.; Roessler, M.; Meier, F.; Schoffer, O. Targeted and Checkpoint Inhibitor Therapy of Metastatic Malignant Melanoma in Germany, 2000–2016. Cancers 2020, 12, 2354. https://doi.org/10.3390/cancers12092354
Hellmund P, Schmitt J, Roessler M, Meier F, Schoffer O. Targeted and Checkpoint Inhibitor Therapy of Metastatic Malignant Melanoma in Germany, 2000–2016. Cancers. 2020; 12(9):2354. https://doi.org/10.3390/cancers12092354
Chicago/Turabian StyleHellmund, Peter, Jochen Schmitt, Martin Roessler, Friedegund Meier, and Olaf Schoffer. 2020. "Targeted and Checkpoint Inhibitor Therapy of Metastatic Malignant Melanoma in Germany, 2000–2016" Cancers 12, no. 9: 2354. https://doi.org/10.3390/cancers12092354